LMRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lumexa Imaging Holdings Inc (LMRI) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock has strong analyst support with multiple 'Buy' and 'Strong Buy' ratings, a favorable growth outlook, and secular tailwinds in the imaging sector. Despite weak financials in the latest quarter, the company's long-term growth potential and favorable market positioning make it a compelling investment.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 65.766, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its R1 resistance level of 13.847 in pre-market, suggesting limited immediate upside but potential for a breakout if momentum continues.
Strong analyst ratings with multiple 'Buy' and 'Strong Buy' recommendations and price targets in the $22-$23 range.
Secular tailwinds in the imaging sector, including increased demand for outpatient diagnostic imaging and demographic shifts.
Favorable growth drivers like new center openings, advanced imaging mix, and joint ventures.
Weak financial performance in the latest quarter, with negative net income (-$25.06M) and EPS (-0.19).
Bearish moving averages, indicating potential short-term weakness.
Lack of recent news or significant insider or hedge fund trading activity.
In Q4 2024, revenue was flat YoY at $248.03M, with a net loss of $25.06M and an EPS of -0.19. Gross margin improved slightly to 11.58%. The financials indicate weak profitability but stable revenue.
Analysts are highly optimistic about LMRI, with multiple firms initiating coverage or upgrading the stock to 'Buy' or 'Strong Buy' with price targets of $22-$23. Analysts highlight the company's strong local market positions, growth potential, and favorable industry trends as key drivers for long-term performance.
